Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome
Condition(s) studied
Investigational drug(s) / intervention(s)
Collection of clinical data.: Observational study
Study summary
The goal of this observational study is to define the rate of intrauterine parvovirus B19 infection and fetal/newborn complications after parvovirus B19 infection of pregnant women. Secondary objectives are risk factors, pregnancy outcomes, long-term sequelae and efficacy of the management interventions.
Eligibility
Primary outcome measure(s)
- Percentage of fetuses/newborns with intrauterine B19V infection. — From diagnosis of parvovirus B19 infection in pregnancy to 24/48 hours of life of the newborn.
- Percentage of fetuses/newborns with complications due to B19V intrauterine infection. — From diagnosis of parvovirus B19 infection in pregnancy to 24/48 hours of life of the newborn.
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Fondazione IRCCS Policlinico San Matteo | Pavia | Lombardy | Recruiting |
| ASST degli Spedali Civili di Brescia | Brescia | Italy | Not Yet Recruiting |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | Milan | Italy | Recruiting |
| ASST Fatebenefratelli Sacco | Milan | Italy | Recruiting |
| Fondazione IRCCS San Gerardo dei Tintori | Monza | Italy | Not Yet Recruiting |
More Fondazione IRCCS Policlinico San Matteo di Pavia trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07338279 on ClinicalTrials.gov ↗ ← All trials in Italy